drugset / Trial / NCT02737358

N-acetylcysteine for Tobacco Use Disorder

NCT02737358

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the effects of administering N-Acetylcysteine (NAC) to assist in initial cessation and/or relapse prevention in adult cigarette smokers.

Timeline

Start
2016-08-30
Primary completion
2019-08-01
Completion
2019-10-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator N-acetylcysteine Small molecule 1200 mg

Indications